The association of HIV infection with left ventricular mass/hypertrophy

AIDS Research and Human Retroviruses

Volumn 25, Issue 5, 2009, Pages 475-481

  Mansoor, Ather ^a   Golub, Elizabeth T ^b   Dehovitz, Jack ^a   Anastos, Kathryn ^c   Kaplan, Robert C ^c   Lazar, Jason M ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR RISK; CD4+ T LYMPHOCYTE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKINFOLD THICKNESS; SMOKING; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICEPS BRACHII MUSCLE;

ADULT; ECHOCARDIOGRAPHY; FEMALE; HIV INFECTIONS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 66149164579     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0170     Document Type: Article

References (34)

1. Levy D, Garrison GJ, Savage DD, Kannel WB, and Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990;322:1561-1566.
2. Verdecchia P, Porcellati C, Reboldi G, et al.: Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 2001;104: 2039-2044.
3. Haider AW, Larson MG, Benjamin EJ, and Levy D: Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998;32:1454-1459.
4. Gardin JM, Wagenknecht LE, Anton-Culver H, et al.: Relationship of race, sex, systolic blood pressure levels, and body mass to left ventricular mass in healthy young adults: The CARDIA Study. Circulation 1991;84(4):133.
5. Levy WS, Simon GL, Rios JC, and Ross AM: Prevalence of cardiac abnormalities in human immunodeficiency virus infection. Am J Cardiol 1989;63:86-89.
6. Friis-Møller N, Weber R, Reiss P, et al.: Cardiovascular risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD Study. AIDS 2003;17:1179-1193.
7. Cole JW, Pinto AN, Hebel JR, et al.: Acquired immunodeficiency syndrome and the risk of stroke. Stroke 2004;35(1):51-56.
8. Barbaro G, Di Lorenzo G, Grisorio B, and Barbarini G: Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med 1998;339:1093-1099.
9. Carr A, Samaras K, Burton S, et al.: A syndrome of peripheral lipodystrophy, hyperlipidemia, and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-58.
10. National Center for Health Statistics: The Third National Health and Examination Survey Reference Manuals and Reports. CD-ROM, 2002. Hyattsville: National Center for Health Statistics, 1996.
11. Friedewald WT, Levy RI, and Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
12. Genuth S, Alberti KG, Bennett P, et al.: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160.
13. Grundy SM: Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004;110:227-239.
14. Panel on clinical practices for treatment of HIV infection: Department of Health and Human Services (DHHS); Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents, October 10, 2006.
15. Schiller NB, Shah PM, Crawford M, et al.: Recommendations for quantitation of left ventricle by two-dimensional echo-cardiography. J Am Soc Echocardiogr 1989;2:358-367.
16. Devereux RB, Alonso DR, and Lutas EM: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
17. Devereux RB, Lutas EM, Casale PN, et al.: Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984;4:1222-1230.
18. de Simone G, Daniels SR, Devereux RB, et al.: Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992;20:1251-1260.
19. Nunez E, Arnett DK, Benjamin EJ, et al.: Optimal threshold value for left ventricular hypertrophy in blacks: The atherosclerosis risk in communities study. Hypertension 2005; 45:58-63.
20. Ganau A, Devereux RB, Roman MJ, et al.: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19:1550-1558.
21. Barbaro G, Barbarini G, and Di Lorenzo G: Early impairment of systolic and diastolic function in asymptomatic HIV-positive patients: A multicenter echocardiographic and echo-Doppler study. AIDS Res Hum Retroviruses 1996;12: 1559-1563.
22. Lipshultz SE, Easley KA, Orav EJ, et al.: Left ventricular structure and function in children infected with human immunodeficiency virus. Circulation 1998;97:1246-1256.
23. Martínez-García T, Sobrino JM, Pujol E, Galvez J, Benítez E, and Girón-González JA: Ventricular mass and diastolic function in patients infected by human immunodeficiency virus. Heart 2000;84:620-624.
24. Samaan SA, Foster A, Raizada V, Schade DS, Koster F, and Crawford MH: Myocardial atrophy in acquired immunodeficiency syndrome-associated wasting. Am Heart J 1995; 130:823-827.
25. Altieri PI, Climent C, Lazala G, Velez R, and Torres JV: Opportunistic invasion of the heart in hispanic patients with acquired immunodeficiency syndrome. Am J Trop Med Hyg 1994;51:56-59.
26. Meng Q, Lima J, Lai H, et al.: Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J AIDS 2002;30(3):306-310.
27. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, and Torre D: Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 2000;40(3):282-284.
28. Lund KC and Wallace KB: Direct effects of nucleoside reverse transcriptase inhibitors on rat cardiac mitochondrial bioenergetics. Mitochondrion 2004;4(2-3):193-202.
29. Payne JR, Eleftheriou KI, James LE, et al.: Left ventricular growth response to exercise and cigarette smoking: Data from LARGE Heart Study. Heart 2006;92:1784-1788.
30. Cryer PE, Haymond MW, Santiago JV, and Shah SD: Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-577.
31. Cohen I, Anderson D, Virmani R, et al.: Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome. N Engl J Med 1986;315:628-630.
32. De Castro S, d'Amati G, Cartoni D, et al.: Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection. J Am Coll Cardiol 1994;24:1018-1024.
33. Hense HW, Gneiting B, Muscholl M, et al.: The associations of body size and body composition with left ventricular mass: Impacts for indexation in adults. J Am Coll Cardiol 1998;32(2):451-457.
34. Wachtell K, Bella JN, Liebson PR, et al.: Impact of different partition values on prevalence of left ventricular hypertrophy and concentric geometry in a large hypertensive population: The LIFE study. Hypertension 2000;35:6-12.